Search Results
Cardiovascular Risk and PreventionCardiovascular Risk and Prevention
Browse cardiovascular risk tools from primary to secondary prevention.Browse cardiovascular risk tools from primary to secondary prevention.
Reynolds Risk Score for Cardiovascular Risk in WomenReynolds Risk Score
Estimates 10-year cardiovascular risk in women over age 45 years.Estimates cardiac risk in women over 45.
Cardiovascular Risk in Orthotopic Liver Transplantation (CAR-OLT)CAR-OLT
Predicts cardiovascular risk in orthotopic liver transplantation (OLT).Cardiovascular complication risk in OLT.
American University of Beirut (AUB)-HAS2 Cardiovascular Risk IndexAUB-HAS2
Stratifies cardiovascular risk of patients undergoing noncardiac surgery.Cardiovascular risk stratification.
ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC2013 ASCVD Risk Calculator
Determine 10-year risk of hard ASCVD, i.e. myocardial infarction, stroke, or death due to coronary heart disease or stroke.10-year heart disease or stroke risk.
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT)PREVENT
Predicts 10- and 30-year risk of CVD and CVD subtypes in patients aged 30-79 without known CVD.CVD risk.
ASCVD (Atherosclerotic Cardiovascular Disease) Risk Algorithm including Known ASCVD from AHA/ACCASCVD Risk Algorithm
Determines 10-year risk of hard ASCVD, i.e. myocardial infarction, stroke, or death due to coronary heart disease or stroke, and provides statin recommendations.10-year heart disease or stroke risk and statin recommendations.
Revised Cardiac Risk Index for Pre-Operative RiskRevised Cardiac Risk Index
Estimates risk of cardiac complications after noncardiac surgery.Risk of major cardiac event from surgery.
HFA-ICOS Baseline Cardio-Oncology Risk Assessment for Multi-Targeted Kinase Inhibitors for Chronic Myeloid Leukemia (CML) HFA-ICOS BCR-ABL TKIs for CML
Stratifies cardiotoxicity risk in CML cancer patients scheduled to receive BCR-ABL TKIs.BCR-ABL TKI therapy cardiotoxicity risk assessment.
Systematic Coronary Risk Evaluation 2 (SCORE2)SCORE2
Predicts 10-year CVD risk in patients without prior CVD or diabetes.10-yr CVD risk w/out prior CVD or diabetes.
HFA-ICOS Baseline Cardio-Oncology Risk Assessment for VEGF InhibitorsHFA-ICOS VEGF Inhibitors
Stratifies cardiotoxicity risk in cancer patients scheduled to receive VEGF inhibitor therapy.VEGF inhibitor cardiotoxicity risk assessment.
HFA-ICOS Baseline Cardio-Oncology Risk Assessment for HER2-Targeted TherapiesHFA-ICOS HER2 Therapy
Stratifies cardiotoxicity risk in cancer patients scheduled to receive HER2-targeted therapies.HER2-targeted therapy cardiotoxicity risk assessment.
HFA-ICOS Baseline Cardio-Oncology Risk Assessment for Multiple Myeloma TherapiesHFA-ICOS Multiple Myeloma Therapies
Stratifies cardiotoxicity risk in cancer patients scheduled to receive multiple myeloma therapies.Multiple myeloma therapy cardiotoxicity risk assessment.
Framingham Risk Score for Hard Coronary Heart DiseaseFramingham Risk Score (Hard Coronary Heart Disease)
Estimates 10-year risk of heart attack in patients 30-79 years with no history of CHD or diabetes.Heart attack risk.
HFA-ICOS Baseline Cardio-Oncology Risk Assessment for Combination Rapidly Accelerated Fibrosarcoma (RAF) and Mitogen-Activated Extracellular Signal-Regulated Kinase (MEK) InhibitorsHFA-ICOS RAF-MEK Inhibitors
Stratifies cardiotoxicity risk in cancer patients scheduled to receive combination RAF and MEK inhibitors.RAF-MEK inhibitor cardiotoxicity risk assessment.
Cardiac Anesthesia Risk Evaluation Score (CARE)Cardiac Anesthesia Risk Evaluation Score (CARE)
A simple, clinically derived ordinal classification system that predicts morbidity and mortality after cardiac surgery.Cardiac anesthesia risk classification.
Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes)SCORE2-Diabetes
Predicts 10-year CVD risk in patients with type 2 diabetes.10-yr CVD risk w/ type 2 diabetes.
Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP)SCORE2-OP
Predicts 10-year CVD risk in older patients.Older patients' 10-yr CVD risk.
HFA-ICOS Baseline Cardio-Oncology Risk Assessment for Anthracycline ChemotherapyHFA-ICOS Anthracycline
Stratifies cardiotoxicity risk in cancer patients scheduled to receive anthracycline-based chemotherapy.Anthracycline chemotherapy cardiotoxicity risk assessment.
HAS-BLED Score for Major Bleeding RiskHAS-BLED Score
Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.Bleeding risk with AFib anticoagulation.
Metabolic Score for Insulin Resistance (METS-IR)METS-IR
Predicts risk of type 2 diabetes in previously undiagnosed patients.Type 2 diabetes risk.
Emergency Department Assessment of Chest Pain Score (EDACS)EDACS
Identifies chest pain patients with low risk of major adverse cardiac event.Identifies low risk chest pain, longer but more specific than HEART.
Burch-Wartofsky Point Scale (BWPS) for ThyrotoxicosisBurch-Wartofsky Point Scale
Predicts likelihood that biochemical thyrotoxicosis is thyroid storm.Determines likelihood of thyrotoxicosis.
CKD Prediction in HIV+ PatientsHIV CKD Prediction
Determines probability of HIV patients developing CKD in the next 5 years, if they take tenofivir or not.5 year likelihood of CKD in HIV.
Local Anesthetic Dosing CalculatorLocal Anesthetic Dosing
Doses local anesthetics to help avoid toxic doses.Local anesthetic toxicity prevention.
Contact us